Linezolid in the treatment of multidrug-resistant tuberculosis.
about
Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysisCombating Tuberculosis Infection: A Forbidding ChallengeWHO group 5 drugs and difficult multidrug-resistant tuberculosis: a systematic review with cohort analysis and meta-analysisNew developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanidRising to the challenge: new therapies for tuberculosisCurrent strategies to treat tuberculosisLinezolid-Associated Optic Neuropathy in Drug-Resistant Tuberculosis Patients in Mumbai, IndiaDiscovery and development of SQ109: a new antitubercular drug with a novel mechanism of action.Exploring prospects of novel drugs for tuberculosis.Multidrug-resistant tuberculosis treatment with linezolid-containing regimen.Early Bactericidal Activity of AZD5847 in Patients with Pulmonary Tuberculosis.Linezolid manifests a rapid and dramatic therapeutic effect for patients with life-threatening tuberculous meningitis.Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patientLinezolid for treatment of chronic extensively drug-resistant tuberculosis.Systematic review and meta-analysis of the efficacy and safety of therapy with linezolid containing regimens in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis.Current development and future prospects in chemotherapy of tuberculosisAntimycobacterial Activities of Novel 5-(1H-1,2,3-Triazolyl)Methyl Oxazolidinones.rplC T460C identified as a dominant mutation in linezolid-resistant Mycobacterium tuberculosis strains.New drugs to treat tuberculosis.A Case of Disseminated Multidrug-Resistant Tuberculosis involving the Brain.World Health Organization group 5 drugs for the treatment of drug-resistant tuberculosis: unclear efficacy or untapped potential?Update in tuberculosis and nontuberculous mycobacterial disease 2010.Challenges and opportunities in developing novel drugs for TB.New treatment options for multidrug-resistant tuberculosis.Drug-induced peripheral neuropathy.An Update on Repurposed Medications for the Treatment of Drug-Resistant Tuberculosis.Mycobacterium tuberculosis Mutations Associated with Reduced Susceptibility to Linezolid.Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort.An evolved oxazolidinone with selective potency against Mycobacterium tuberculosis and gram positive bacteria.Linezolid-resistant Enterococcus faecalis infection following prolonged low-dosage linezolid treatment for multi-drug-resistant tuberculosis.Neuroprotective potential of Linezolid: a quantitative and distribution study via mass spectrometry.The spread of drug-resistant tuberculosis in children: an Italian case series.Optic neuropathy secondary to Linezolid for multidrug-resistant mycobacterial spinal tuberculosis.Repurposing and Revival of the Drugs: A New Approach to Combat the Drug Resistant Tuberculosis.Clinical benefit of delamanid (OPC-67683) in the treatment of multidrug-resistant tuberculosis patients in China.Use of linezolid in neonatal and pediatric inpatient facilities--results of a retrospective multicenter survey.Treatment of Tuberculous Meningitis and Its Complications in Adults.Outcomes of pulmonary MDR-TB: impacts of fluoroquinolone resistance and linezolid treatment.
P2860
Q26743380-78970BBD-7087-4D00-9E24-0F62C92E4794Q26750683-79F8A72A-1B9B-41F0-908D-C315E3A8103FQ26852253-849B3FD5-18DE-4A25-8642-DE3E6AF0B57FQ27003210-50E4E07E-354C-47BE-9222-D27164042A2DQ27011672-875C90A2-27A2-4C3D-8ED2-E5A081747A2EQ28075252-07547434-5F03-4E94-90EA-0E336D0C96E9Q28553960-A6D540B2-076A-41E1-9539-F7FD34DCA267Q30419537-66E4B0A2-EFA7-4A43-A312-2D22A0AC93D1Q30421213-80B530C6-34D4-4BB8-B1F3-F6CC57AAAB9AQ33416970-01D0DE02-07C6-46AB-A3E3-69418BD6581BQ33434791-BD5748B6-6C6A-4C71-84CD-15F03F77AFA8Q34299173-9771F1F9-879E-4472-9B00-F5BD7AC554B7Q34466858-5ADAA0CC-B032-42F8-B5B2-A2B1FDB1183AQ34644127-A9CA96B2-0948-4FD6-81B9-E4D12B4676C5Q35568367-1B395ADA-9243-4804-A54A-BDC804107B04Q35705874-C355031C-C5C0-4E3E-AE8D-978540A72413Q35936637-F872C1A9-000A-439F-A72F-1409E7031F8FQ35941267-A93CB4D7-6FA2-4DB4-8AFD-D1A1566F5404Q36018409-EB6B1E81-E44D-4CF1-87C7-5327115DE384Q36809127-CF51E2C9-2A91-407E-9319-EC32F5075977Q36957270-E2584322-E489-4E1C-A66F-208B54D488DAQ37902000-58768702-A703-4AC0-AA60-386AED9F4540Q37924294-8C3C360D-8C5B-43B3-9332-782D732CA184Q38024041-8EE09952-8401-4EC2-8379-BA9B4EC0D58AQ38208565-9E081137-F495-439B-86AD-206709A295BCQ38885365-FB756945-C018-49FB-B813-EA1CAE3281B4Q39514292-0BBA74F9-4624-4EC4-B4BD-B2D8C0DD4305Q41699273-2B9B91BB-5374-4554-8257-F423B06CB311Q41864236-EA02733F-C3A2-4B40-B679-F848B67120EAQ41919152-14601189-AD6D-4C44-ACD1-A0CF4D3535C5Q42101970-B8350ED0-EBEB-4D42-88C7-3C33A4694BE2Q42230437-A08BE4A3-90F1-4BE0-9618-FD85C8BAC1DFQ43468690-D247E829-23C8-477C-BE3D-B1D2FB47CE67Q47429675-2498415C-E049-4FC6-A1B7-D60DCA586A33Q48185912-030C89E2-389F-4D10-9628-EE9B992C9ADDQ51505589-0241F6AE-EC07-4A6A-AC07-414AB78BC219Q52680275-BB735774-E7D0-4D13-A170-48E868890A8EQ53205517-2B1F9F94-7527-43B3-B4C0-DD78F78E557F
P2860
Linezolid in the treatment of multidrug-resistant tuberculosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Linezolid in the treatment of multidrug-resistant tuberculosis.
@ast
Linezolid in the treatment of multidrug-resistant tuberculosis.
@en
type
label
Linezolid in the treatment of multidrug-resistant tuberculosis.
@ast
Linezolid in the treatment of multidrug-resistant tuberculosis.
@en
prefLabel
Linezolid in the treatment of multidrug-resistant tuberculosis.
@ast
Linezolid in the treatment of multidrug-resistant tuberculosis.
@en
P2093
P356
P1476
Linezolid in the treatment of multidrug-resistant tuberculosis.
@en
P2093
P356
10.1086/648675
P407
P577
2010-01-01T00:00:00Z